Clinical Trial

Proton SBRT for Spinal Metastasis

Recruiting
View on ClinicalTrials.gov →
Summary
This is a single-arm pilot study of proton stereotactic body radiotherapy (SBRT) for nonhematologic spinal metastasis in patients with complex lesions that are unable to be effectively treated with standard of care photon SBRT defined as inability to develop a photon SBRT plan that achieves adequate coverage (≥80% planning treatment volume (PTV) coverage)) with a prescription dose of 30 Gy in 5 fractions.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-19; most recent amendment 2026-04-27.
Status change: Not Yet Recruiting → Recruiting 2025-04-28
Trial Details
NCT Number NCT06895564
Lead Sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: Sibley Foundation
Conditions Spinal Metastasis
Enrollment 12 participants
Start Date 2025-04-22
Primary Completion 2030-04 (estimated)
Study Completion 2030-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-29